The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Lupin and its alliance partner Natco received clearance from the FDA for bosentan tablets for oral suspension, 32 mg, which ...

Circana provides Ahold Delhaize USA companies with analytical support to inform decision-making, boost supply chain ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...

The rise in GLP-1 drugs is undeniable. Morgan Stanley projects that by 2035, 24 million Americans, or 7% of the population, ...

Ozempic is synonymous with weight loss for ... “I understand there is an argument that obesity is a chronic disease like hypertension, diabetes, and once you need to be on it, you should be ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

EXCLUSIVE: The latest figures are all too clear: we are in the middle of an epidemic of diabetes.

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...